Iterum Therapeutics PLC is a pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance ... Iterum Therapeutics PLC is a pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. Show more
DUBLIN, Ireland and CHICAGO, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Company), a company focused on delivering next generation oral and IV antibiotics to treat...
DUBLIN and CHICAGO, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), (the Company), a company focused on delivering next generation oral and IV antibiotics to treat...
-- ORLYNVAHTM Approved by FDA on October 25, 2024— --Company to Host Conference Call Today at 8:30 a.m. EDT-- DUBLIN and CHICAGO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc...
DUBLIN and CHICAGO, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Company), a company focused on delivering next generation oral and IV antibiotics to treat...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.025 | 1.64473684211 | 1.52 | 1.75 | 1.51 | 836504 | 1.57225507 | CS |
4 | -0.265 | -14.6408839779 | 1.81 | 1.85 | 1.46 | 641395 | 1.56598615 | CS |
12 | 0.295 | 23.6 | 1.25 | 3.02 | 1.25 | 1014759 | 1.95250728 | CS |
26 | 0.405 | 35.5263157895 | 1.14 | 3.02 | 0.808 | 1680632 | 1.75141449 | CS |
52 | 0.125 | 8.80281690141 | 1.42 | 3.02 | 0.808 | 940543 | 1.72281838 | CS |
156 | 1.135 | 276.829268293 | 0.41 | 3.1305 | 0.175 | 861034 | 0.95425735 | CS |
260 | -1.055 | -40.5769230769 | 2.6 | 6.02 | 0.175 | 3641383 | 1.35452951 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales